Clinical Trial Update: Patiromer Utility as an Adjunct Treatment in Patients Needing Urgent Hyperkalemia Management [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on patiromer as an adjunct for urgent hyperkalemia management has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperkalemia

Drugs mentioned

• Patiromer (patiromer)

Snippet

Sponsor: Comprehensive Research Associates | Conditions: Hyperkalemia | Phase 4 | Status: TERMINATED